Amphotericin B lipid complex: treatment of invasive fungal infections in patients refractory to or intolerant of amphotericin B deoxycholate

References

• AdedoyinABernardoJFSwensonCE1997Pharmacokinetic profile of Abelcet (amphotericin B lipid complex injection): combined experience from phase I and phase II studiesAntimicrob Agents Chemother41220189333048
   PubMed Web of Science ®Google Scholar
• Adler-ShohetFCArrietaACRossLA2001Amphotericin B lipid complex in neonates with invasive candidiasisClin Infect Dis331198
   Web of Science ®Google Scholar
• AlexanderBDWingardJR2005Study of renal safety in amphotericin B lipid complex-treated patientsClin Infect Dis40Suppl 6S414S2115809928
   PubMed Web of Science ®Google Scholar
• BaddourLMPerfectJROstrosky-ZeichnerL2005Successful use of amphotericin B lipid complex in the treatment of cryptococcosisClin Infect Dis40Suppl 6S409S1315809927
   PubMed Web of Science ®Google Scholar
• BarrettJPVardulakiKAConlonC2003A systematic review of the antifungal effectiveness and tolerability of amphotericin B formulationsClin Ther25129532012867214
   PubMed Web of Science ®Google Scholar
• CannonJPGareyKWDanzigerLH2001A prospective and retrospective analysis of the nephrotoxicity and efficacy of lipid-based amphotericin B formulationsPharmacother21110714
   PubMed Web of Science ®Google Scholar
• ChamilosGLunaMLewisRE2006Invasive fungal infections in patients with hematologic malignancies in a tertiary care cancer center: an autopsy study over a 15-year period (1989–2003)Haematologica91986916757415
   PubMed Web of Science ®Google Scholar
• ChandrasekarPHItoJI2005Amphotericin B lipid complex in the management of invasive aspergillosis in immunocompromised patientsClin Infect Dis40Suppl 6S392S40015809925
   PubMed Web of Science ®Google Scholar
• FlemingRVKantarjianHMHusniR2001Comparison of amphotericin B lipid complex (ABLC) vs. AmBisome in the treatment of suspected or documented fungal infections in patients with leukemiaLeukemia Lymphoma405112011426524
   PubMed Web of Science ®Google Scholar
• GilgadoFSerenaCCanoJ2006Antifungal susceptibilities of the species of the Pseudallescheria boydii complexAntimicrob Agents Chemother5042111317015631
   PubMed Web of Science ®Google Scholar
• HawkinsJLBaddourLM2003Candida lusitaniae infections in the era of fluconazole availabilityClin Infect Dis36e14e1812522762
   PubMed Web of Science ®Google Scholar
• HerbrechtRAuvrignonAAndresE2001Efficacy of amphotericin B lipid complex in the treatment of invasive fungal infections in immunosuppressed paediatric patientsEur J Clin Microbiol Infect Dis20778211305476
   PubMed Web of Science ®Google Scholar
• HerbrechtRDenningDWPattersonTF2002Voriconazole versus amphotericin B for primary therapy of invasive aspergillosisN Engl J Med3474081512167683
   PubMed Web of Science ®Google Scholar
• Hooshmand-RadRChuAGotzV2005Use of amphotericin B lipid complex in elderly patientsJ Infect502778715845425
   PubMed Web of Science ®Google Scholar
• ItoJIChandrasekarPHHooshmand-RadR2005Effectiveness of amphotericin B lipid complex (ABLC) treatment in allogeneic hematopoietic cell transplant (HCT) recipients with invasive aspergillosis (IA)Bone Marrow Transplant36873716113663
   PubMed Web of Science ®Google Scholar
• ItoJIHooshmand-RadR2005Treatment of Candida infections with amphotericin B lipid complexClin Infect Dis40Suppl 6S3849115809924
   PubMed Web of Science ®Google Scholar
• JanoffASPerkinsWRSaletanSI1993Amphotericin B lipid complex (ABLC): a molecular rationale for the attenuation of amphotericin B related toxicitiesJ Liposomes Res345171
   Google Scholar
• JohnsonPCWheatLICloudGA2002Safety and efficacy of liposomal amphotericin B compared with conventional amphotericin B for induction therapy of histoplasmosis in patients with AIDSAnn Intern Med137105912118965
   PubMed Web of Science ®Google Scholar
• KontoyiannisDPLionakisMSLewisRE2005Zygomycosis in a tertiary care cancer center in the era of Aspergillus-active antifungal therapy: a case-controled observational study of 27 recent casesJ Infect Dis1911350915776383
   PubMed Web of Science ®Google Scholar
• LarkinJAMonteroJA2003Efficacy and safety of amphotericin B lipid complex for zygomycosisInfect Med202016
   Web of Science ®Google Scholar
• LewisRELiaoGHouJ2007Comparative analysis of amphotericin B lipid complex and liposomal amphotericin B kinetics of lung accumulation and fungal clearance in a murine model of acute invasive pulmonary aspergillosisAntimicrob Agents Chemother5112535817261624
   PubMed Web of Science ®Google Scholar
• LindenPWilliamsPChanKM2000Efficacy and safety of amphotericin B lipid complex in injection (ABLC) in solid-organ transplant recipients with invasive fungal infectionsClin Transplant143293910945204
   PubMed Web of Science ®Google Scholar
• MartinGSManninoDMEatonS2003The epidemiology of sepsis in the United States from 1979 through 2000N Engl J Med34815465412700374
   PubMed Web of Science ®Google Scholar
• MartinoR2004Efficacy, safety and cost-effectiveness of amphotericin B lipid complex (ABLC): a review of the literatureCurr Med Res Opin2048550415119986
   PubMed Web of Science ®Google Scholar
• MartinoRCortesMSubiraM2005Efficacy and toxicity of intermediate dose amphotericin B lipid complex as a primary or salvage treatment of fungal infections in patients with hematologic malignanciesLeuk Lymphoma4614293516194888
   PubMed Web of Science ®Google Scholar
• Ostrosky-ZeichnerLPappasPG2006Invasive candidiasis in the intensive care unitCrit Care Med348576216505666
   PubMed Web of Science ®Google Scholar
• PappasPG2005Amphotericin B lipid complex in the treatment of invasive fungal infections: results of the Collaborative Exchange of Antifungal Research (CLEAR), an industry-supported patient registryClin Infect Dis40Suppl 6S379S8315809923
   PubMed Web of Science ®Google Scholar
• PerfectJR2005Treatment of non-aspergillus molds in immunocompromised patients with amphotericin B lipid complexClin Infect Dis40Suppl 6S401S40815809926
   PubMed Web of Science ®Google Scholar
• PerfectJRMarrKAWalshTJ2003Voriconazole treatment for less-common, emerging, or refractory fungal infectionsClin Infect Dis3611223112715306
   PubMed Web of Science ®Google Scholar
• RodenMMZaoutisTEBuchananWL2005Epidemiology and outcome of zygomycosis: a review of 929 reported casesClin Infect Dis416345316080086
   PubMed Web of Science ®Google Scholar
• SaagMSGraybillRJLarsenRA2000Practice guidelines for the management of cryptococcal disease. Infectious Diseases Society of AmericaClin Infect Dis307101810770733
   PubMed Web of Science ®Google Scholar
• SafdarAMaJWalshTJ2007Nephrotoxicity associated with amphotericin B (AmB) lipid complex (ABLC) vs. liposomal amphotericin B (L-AmB)47th Interscience Conference on Antimicrobial Agents and Chemotherap Abstract M-1168442
   Google Scholar
• SharkeyPKGraybillJRJohnsonES1996Amphotericin B lipid complex compared with amphotericin B in the treatment of cryptococcal meningitis in patients with AIDSClin Infect Dis22315218838189
   PubMed Web of Science ®Google Scholar
• SuttonDASancheSERevankarSG1999In vitro amphotericin B resistance in clinical isolates of Aspergillus terreus, with a head to head comparison to voriconazoleJ Clin Microbiol372343510364610
   PubMed Web of Science ®Google Scholar
• van BurikJAHareRSSolomonHF2006Posaconazole is effective as salvage therapy in zygomycosis: a retrospective summary of 91 casesClin Infect Dis42e61e516511748
   PubMed Web of Science ®Google Scholar
• WalshTJHiemenzJWSeibelNL1998Amphotericin B lipid complex for invasive fungal infections: Analysis of safety and efficacy in 556 casesClin Infect Dis261383969636868
   PubMed Web of Science ®Google Scholar
• WheatLICloudGJohnsonPC2001Clearance of fungal burden during treatment of disseminated histoplasmosis with liposomal amphotericin B versus itraconazoleAntimicrob Agents Chemother452354711451696
   PubMed Web of Science ®Google Scholar
• WileyJMSeibelNLWalshTJ2005Efficacy and safety of amphotericin B lipid complex in 548 children and adolescents with invasive fungal infectionsPediatr Infect Dis J241677415702047
   PubMed Web of Science ®Google Scholar
• WingardJR1997Efficacy of amphotericin B lipid complex injection (ABLC) in bone marrow transplant recipients with life-threatening systemic mycosesBone Marrow Transplant1934379051244
   PubMed Web of Science ®Google Scholar
• WingardJRWhiteMHAnaissieE2000A randomized, double-blind comparative trial evaluating the safety of liposomal amphotericin B versus amphotericin B lipid complex in the empirical treatment of febrile neutropeniaClin Infect Dis3111556311073745
   PubMed Web of Science ®Google Scholar